Printed from Voxsanity (voxsanity.com.au) — NCT06516822 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Atrial Fibrillation
Atrial Fibrillation Trial, Recruiting
NCT06516822
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have atrial fibrillation (an irregular heart rhythm) that has lasted continuously for between 1 and 3 years
- People whose atrial fibrillation causes symptoms and has not responded to at least one medication designed to control heart rhythm
- People between 18 and 75 years of age
- People whose left atrial chamber of the heart measures between 43 and 55 mm on a specific type of heart ultrasound
- People who have had their atrial fibrillation recorded on a heart monitor within the past 3 years
- People who are willing and able to follow the study requirements and sign a consent form
Who may not be able to join:
- People whose atrial fibrillation comes and goes (paroxysmal), or has lasted less than 1 year or more than 3 years continuously
- People who have a blood clot inside the upper left chamber of the heart
- People who have previously had a catheter-based procedure to treat atrial fibrillation
- People with serious structural heart conditions, such as severe valve disease or certain types of heart muscle disease
- People whose left atrial chamber measures more than 55 mm on the specific heart ultrasound measurement used in this trial
- People whose heart pumping function is below 40% (as measured by a specific heart scan)
- People who cannot take blood-thinning medications such as heparin, warfarin, or newer anticoagulant tablets
- People who are planned to have a combined procedure for both atrial fibrillation treatment and a device to close a small pouch in the heart at the same time
- People with an allergy to alcohol or to contrast dye used in medical imaging
- People who have taken a type of antibiotic called cephalosporins within 72 hours before the planned procedure
- People with high blood pressure in the arteries of the lungs (pulmonary artery pressure above 50 mmHg)
- People with unstable chest pain (unstable angina)
- People who have had a procedure to open blocked heart arteries (PCI) within the past 3 months
- People who have had any surgery within the past 6 months
- People who are being considered for a heart transplant
- People who have had a blood clot event (such as a stroke or clot in a blood vessel) within the past 6 months
- People diagnosed with a type of heart tumour called an atrial myxoma
- People with serious lung or breathing conditions
- People with an active infectious disease
- People with a systemic immune (autoimmune) condition that is not well controlled
- People with blood cancers that have not been successfully treated
- People with solid organ cancers that have not been successfully treated
- People with an underactive or overactive thyroid that has not been treated
- People with significantly reduced liver function, based on specific blood test results
- People with severe kidney failure who require dialysis
- People with other serious heart rhythm problems, such as a dangerous fast heart rhythm originating in the lower chambers of the heart
- People who are pregnant or breastfeeding
- People with a diagnosed psychiatric condition
- People with a body mass index (a measure of body weight relative to height) below 18.5 or 30 or above
- People whose life expectancy is estimated to be less than 2 years
- People who are unwilling or unable to give informed consent or to attend follow-up appointments
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
Contact this trial
Principal Investigator: Fengxiang Zhang, MD, The First Affiliated Hospital with Nanjing Medical University
Phone: +86 18651908170
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
31 July 2024
Est. completion
1 December 2027
Where this trial is recruiting
🇨🇳 China
Primary endpoints
Freedom from any documented atrial arrhythmia off AADs
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.